The mitogenic and anti-apoptotic activity of tumor conditioned medium on endothelium

Clinical Hemorheology and Microcirculation

Volumn 29, Issue 3-4, 2003, Pages 375-382

  Li, Ailing ^a   Li, Hongwei ^a   Zhang, Jing ^a   Jin, Gang ^b   Xiu, Ruijuan ^a  

^a Chinese Academy of Medical Sciences   (China)

^b INSTITUTE OF MECHANICS   (China)

Author keywords

Apoptosis; Cell cycle; Endothelium; Proliferation; Tumor conditioned medium

Indexed keywords

ANGIOGENIC FACTOR;

APOPTOSIS; CANCER CELL CULTURE; CELL CYCLE; CELL GROWTH; CELL LINE; CELL PROLIFERATION; CONFERENCE PAPER; ENDOTHELIUM; ENDOTHELIUM CELL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MITOGENESIS; UMBILICAL VEIN;

ANGIOGENESIS INDUCING AGENTS; APOPTOSIS; BREAST NEOPLASMS; CELL CYCLE; CELL LINE, TUMOR; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; FEMALE; FLOW CYTOMETRY; HUMANS; HYDROGEN PEROXIDE; MITOSIS; UMBILICAL VEINS;

EID: 1642521688     PISSN: 13860291     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (27)

1. K.J. Kim, B. Li, J. Winer et al., Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumor growth in vivo, Nature 362 (1993), 841-844.
2. J. Folkman, Tumor angiogenesis: therapeutuc implication, N. Engl. J. Med. 285 (1971), 1182-1186.
3. J. Folkman, Antiangiogenesis: new concept for therapy of solid tumors, Ann. Surg. 175 (1972), 408-416.
4. R.J. Xiu, G.G. Duan and G.F. Mu, The study on angiogenesis induced by SP2/0 and Hela cell, Zhong. Hua. Zhong. Liu. 9 (1987), 95-97.
5. R.J. Xiu, Tumor and microcirculation, Zhong. Hua. Zhong. Liu. 6 (1985), 257-260.
6. R. Kerbel and J. Folkman, Clinical translation of angiogenesis inhibitors, Cancer 2 (2002), 727-739.
7. A. Eberhard, S. Kahlert and V. Goede, Heterogeneity of angiogenesis and blood vessel maturation in human tumors: Impliccation for antiangiogenic tumor therapies, Cancer Res. 60 (2000), 1388-1393.
8. R.L. Engerman, D. Pfaffenbach and D. Davis, Cell turnover of capillary, Lab. Invest. 17 (1967), 738-743.
9. G.D. Yancopoulos, S. Davis, N.W. Gale et al., Vascular-specific growth factors and blood vessel formation, Nature 407 (2000), 242-248.
10. W. Risau, Mechanism of angiogenesis, Nature 386 (1997), 671-674.
11. M. O'Reilly, T. Boehm, Y. Shing et al., Endostatin: an endogenous inhibitor of angiogenesis and tumor growth, Cell 88 (1997), 277-285.
12. S.D. Jia, H.W. Li, R.-J. Xiu et al., Anticancer treatment of endostatin gene therapy by targeting tumor neovasculature in C57/BL mice, Clin. Hemorheol. Microcirc. 23 (2000), 1-7.
13. T. Tanaka, H. Manome, D. Kufe et al., Viral vector mediated transfer of angiostatin for the treatment of malignant gliomas, Proc. Am. Assoc. Cancer Res. Annu. Meet. 38 (1997), 269-274.
14. E. A. Jaffe, R.L. Nachman, C.G. Becker and C.R. Minick, Culture of human endothelial cells derived from umbilical veins: identification by morphological and immunological criteria, J. Clin. Invest. 52 (1973), 2745-2756.
15. W. Holnthoner, M. Pillinger, M. Groger et al., Fibroblast growth factor-2 induces Lef/Tcf-dependent transcription in human endothelial cells, J. Bio. Chem. 277 (2002), 45847-45853.
16. P.W. Hewett, Identification of tumor-induced changes in endothelial cell surface protein expression: an in vitro model, Int. J. Biochem & Cell. Biol. 33 (2001), 325-335.
17. 2-induced apoptosis of human endothelial cells by modulation of the glutathione redox cycle and nitric oxide synthase, Arterioscler. Thromb. Vasc. Biol. 17 (1997), 3588-3592.
18. G.D. Yancopoulos, S. Davis, N.W. Gale et al., Vascular-specific growth factors and blood vessel formation, Nature 407 (2000), 242-248.
19. P.W. Hewett and J.C. Murray, Modulation of human endothelial cell procoagulant activity in tumour models in vitro, Int. J. Cancer 66 (1996), 784-789.
20. Q.D. Wu, J.H. Wang, D. Bouchier-Hayes and H.P. Redmond, Neutrophil-induced transmigration of tumor-conditioned medium is facilitated by granulocyte-macrophage colony-stimulating factor, Eur. J. Surg. 166 (2000), 361-366.
21. S.H. Xu, J.H. Liao and W.Y. Yu, Role of Urokinase plasminogen activator system in the invasiveness of human breast cancer, J. Shanghai Med. Univ. 27 (2000), 453-456.
22. P.C. Brooks, A.M. Montgomery, M. Rosenfeld et al., Integrin antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels, Cell 79 (1994), 1157-1164.
23. K.P. Claffey, L.F. Brown, L.F. del Aguila et al., Expression of vascular permeability factor/vascular endothelial growth factor by melanoma cells increases tumor growth, angiogenesis, and experimental metastasis, Cancer. Res. 56 (1996), 172-181.
24. D. Donovan, J.H. Harmey, D. Toomey et al., Transforming growth factor 1 regulation of vascular endothelial growth factor production by breast cancer cells, Ann. Surg. Oncol. 4 (1997), 621-627.
25. D.A. McNamara, J.H. Harmey, T.N. Walsh et al., Significance of angiogenesis in cancer therapy, Br. J. Surg. 85 (1998), 1044-1055.
26. K. Gupta, S. Ramakrishnan, P.V. Browne et al., A novel technique for culture of human dermal microvascular endothelial cells under either serum-free or serum-supplemented conditions: Isolation by panning and stimulation with vascular endothelial growth factor, Exp. Cell. Res. 230 (1997), 244-251.
27. K. Gupta, S. Kshirsagar, W. Li, L. Gui et al., VEGF prevent apoptosis of human microvascular endothelial cells via opposing effects on MAPK/ERK and SAPK/JNK signaling, Exp. Cell. Res. 247 (1999), 495-504.